San Diego | Capital Strategy in Today’s Market: What Matters Most for CFOs Now
Market conditions continue to evolve, and with ongoing uncertainty shaping investor sentiment, biotech CFOs are taking a more strategic and creative approach to capital deployment and value creation. We will begin the program with a brief market and investor update from Biocom's CEO, Tim Scott, reflecting insights from his recent delegation to China with fellow […]
